Obesity Trial, Recruiting NCT07633639 Sponsor: China-Japan Friendship Hospital Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT07633639
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are having a laparoscopic sleeve gastrectomy (a type of weight-loss stomach surgery) for the first time.
  • People with a Body Mass Index (BMI) of 30 or higher, which is a standard measure of body weight relative to height.
  • People who have been diagnosed with metabolic syndrome (a cluster of conditions such as high blood pressure, high blood sugar, and excess body fat) or type 2 diabetes, based on standard medical criteria.
  • People between 18 and 60 years of age (inclusive).
  • People who are willing to take part and have signed a consent form agreeing to participate.

Who may not be able to join:

  • People who have used a type of medication called GLP-1 receptor agonists (such as medications used for diabetes or weight loss) in the six months before surgery.
  • People who have previously had any type of weight-loss or metabolic surgery.
  • People who experience serious complications after surgery that require a second operation, such as significant bleeding or a leak at a surgical join.
  • People who do not meet the standard medical criteria for weight-loss surgery.
  • People with severe liver or kidney disease (confirm with trial site for specific test results).
  • People with an active cancer diagnosis, with the exception of certain common skin cancers.
  • People with autoimmune conditions that require medication to suppress the immune system.
  • People with psychiatric conditions that are not well controlled, such as active psychosis or severe depression.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8618612256920

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
China-Japan Friendship Hospital
Registry
ClinicalTrials.gov
Start date
1 May 2026
Est. completion
1 May 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Percentage of weight loss.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov